Regulatory Strategy

REGULATORY STRATEGY & DUE DILIGENCE SERVICES

Our compressive consulting services offer guidance and validation throughout each product development phase including strategy, compliance support, and due diligence.

Regulatory Strategy and Leading Regulatory Agency meetings (Like INTERACT, Pre-IND, EOP 1 and 2 meetings, Type C guidance meetings, Pre-NDA and BLA meetings, Scientific Advice with EMA (SAWP, EMA)), Liaison Services, Regulatory Submissions, Orphan Designation Strategy, and Regulatory compliance.

SERVICES AT EVERY STAGE

Biosimilars

Regulatory Strategy

Global Drug Development

Regulatory Filings

Orphan Drug Designation

Pharmacokinetics

Pharmacodynamics

BA/BE studies

505(b)(2) Strategy

Clinical Pharmacology

Government Liasioning

Liasion

Analytical Skills

Leadership

Team Building

Regulatory Affairs

Regulatory Submissions

Pharmaceutical Industry

Drug Development

Clinical Development

Technology Transfer

FDA

Clinical Trials

GMP